 Plasma antigen levels lipoprotein-associated coagulation inhibitor patient samples Human plasma inhibitor tissue factor-initiated coagulation lipoprotein-associated coagulation inhibitor LACI extrinsic pathway inhibitor EPI competitive fluorescent immunoassay plasma concentration LACI samples normal individuals patients variety diseases LACI concentration adult control population mean mean value ng/mL nmol/L Plasma LACI levels patients severe chronic hepatic failure warfarin therapy primary pulmonary hypertension thrombosis lupus anticoagulant Plasma LACI antigen patients gram-negative bacteremia evidence disseminated intravascular coagulation Plasma LACI levels women early stages labor patients intravenous tissue-type plasminogen activator patients intravenous heparin radioligand blot pre- post-heparin plasma samples increase form LACI low levels plasma LACI antigen patients homozygous abetalipoproteinemia hypobetalipoproteinemia diseases low plasma levels apolipoprotein containing lipoproteins injection heparin patient homozygous abetalipoproteinemia plasma LACI antigen level level comparable normal individuals heparin treatment